Amnon Hoffman

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Multiple Sclerosis

Monoclonal Antibody

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chaim Gilon, Michal Klazas, Adi Lahiani, Adi Schumacher-Klinger, Shira Merzbach, Johnny N Naoum, Haim Ovadia, Limor Rubin, Susan Cornell-Kennon, Erik M Schaefer, Jehoshua Katzhendler, Cezary Marcinkiewicz, Amnon Hoffman, Ephraim Yavin
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis. JACS Au 1 (12) (2021)
Dvora Izgelov, Aviva Regev, Abraham Avi J Domb, Amnon Hoffman
Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats. Molecular pharmaceutics 17 (6) (2020)
Shira Dishon, Adi Schumacher-Klinger, Chaim Gilon, Amnon Hoffman, Gabriel Nussbaum
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88. Molecular pharmaceutics 16 (4) (2019)
Adi Schumacher-Klinger, Joseph Fanous, Shira Merzbach, Michael Weinmüller, Florian Reichart, Andreas F B Räder, Agata Gitlin-Domagalska, Chaim Gilon, Horst Kessler, Amnon Hoffman
Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway. Molecular pharmaceutics 15 (8) (2018)
Dvora Izgelov, Irina Cherniakov, Gefen Aldouby Bier, Abraham J Domb, Amnon Hoffman
The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability. Molecular pharmaceutics 15 (4) (2018)